Essential	O
role	O
of	O
alveolar	B-cell_type
macrophages	I-cell_type
in	O
intrapulmonary	O
activation	O
of	O
NF-kappaB	B-protein
.	O

Acute	O
inflammatory	O
injury	O
in	O
rat	O
lung	O
induced	O
by	O
deposition	O
of	O
immunoglobulin	B-protein
G	I-protein
immune	I-protein
complexes	I-protein
requires	O
expression	O
of	O
cytokines	B-protein
and	O
chemokines	B-protein
as	O
well	O
as	O
activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappaB	I-protein
.	O

There	O
is	O
little	O
direct	O
evidence	O
regarding	O
the	O
role	O
of	O
alveolar	B-cell_type
macrophages	I-cell_type
in	O
these	O
activation	O
events	O
.	O

In	O
the	O
present	O
studies	O
,	O
rat	O
lungs	O
were	O
depleted	O
of	O
alveolar	B-cell_type
macrophages	I-cell_type
by	O
airway	O
instillation	O
of	O
liposome-encapsulated	O
dichloromethylene	O
diphosphonate	O
.	O

These	O
procedures	O
,	O
which	O
greatly	O
reduced	O
the	O
number	O
of	O
retrievable	O
alveolar	B-cell_type
macrophages	I-cell_type
,	O
suppressed	O
activation	O
of	O
lung	B-protein
NF-kappaB	I-protein
in	O
the	O
inflammatory	O
model	O
.	O

In	O
addition	O
,	O
bronchoalveolar	O
lavage	O
levels	O
of	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
and	O
the	O
CXC	B-protein
chemokine	I-protein
,	O
macrophage	B-protein
inflammatory	I-protein
protein-2	I-protein
,	O
were	O
substantially	O
reduced	O
.	O

In	O
parallel	O
,	O
upregulation	O
of	O
the	O
lung	B-protein
vascular	I-protein
adhesion	I-protein
molecule	I-protein
,	O
intercellular	B-protein
adhesion	I-protein
molecule-1	I-protein
,	O
was	O
greatly	O
reduced	O
by	O
intrapulmonary	O
instillation	O
of	O
phosphonate-containing	O
liposomes	O
.	O

Neutrophil	O
accumulation	O
and	O
development	O
of	O
lung	O
injury	O
were	O
also	O
substantially	O
diminished	O
.	O

Lung	O
instillation	O
of	O
TNF-alpha	B-protein
in	O
alveolar	O
macrophage-depleted	O
rats	O
restored	O
the	O
NF-kappaB	B-protein
activation	O
response	O
in	O
whole	O
lung	O
.	O

These	O
data	O
suggest	O
that	O
,	O
in	O
this	O
inflammatory	O
model	O
,	O
initial	O
activation	O
of	O
NF-kappaB	B-protein
occurs	O
in	O
alveolar	B-cell_type
macrophages	I-cell_type
and	O
the	O
ensuing	O
production	O
of	O
TNF-alpha	B-protein
may	O
propagate	O
NF-kappaB	B-protein
activation	O
to	O
other	O
cell	O
types	O
in	O
the	O
lung	O
.	O

Essential	NULL
Role	NULL
of	NULL
Alveolar	NULL
Macrophages	NULL
in	NULL
Intrapulmonary	NULL
Activation	NULL
of	NULL
NF-KB	NULL
Alex	NULL
B.	NULL
Lentsch	NULL
,	NULL
Boris	NULL
J.	NULL
Czermak	NULL
,	NULL
Nicolas	NULL
M.	NULL
Bless	NULL
,	NULL
Nico	NULL
Van	NULL
Rooijen	NULL
,	NULL
and	NULL
Peter	NULL
A	NULL
.	NULL

Ward	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Louisville	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Louisville	NULL
,	NULL
Kentucky	NULL
;	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
School	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Michigan	NULL
;	NULL
Department	NULL
of	NULL
Trauma	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
Medical	NULL
School	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
and	NULL
Immunology	NULL
,	NULL
Vrije	NULL
Universiteit	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
Acute	NULL
inflammatory	NULL
injury	NULL
in	NULL
rat	NULL
lung	NULL
induced	NULL
by	NULL
deposition	NULL
of	NULL
immunoglobulin	NULL
G	NULL
immune	NULL
complexes	NULL
requires	NULL
expression	NULL
of	NULL
cytokines	NULL
and	NULL
chemokines	NULL
as	NULL
well	NULL
as	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
B	NULL
.	NULL

There	NULL
is	NULL
little	NULL
direct	NULL
evidence	NULL
regarding	NULL
the	NULL
role	NULL
of	NULL
alveolar	NULL
macrophages	NULL
in	NULL
these	NULL
activation	NULL
events	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
rat	NULL
lungs	NULL
were	NULL
depleted	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
airway	NULL
instillation	NULL
of	NULL
liposome-encapsulated	NULL
dichloromethylene	NULL
diphosphonate	NULL
.	NULL

These	NULL
procedures	NULL
,	NULL
which	NULL
greatly	NULL
reduced	NULL
the	NULL
number	NULL
of	NULL
retrievable	NULL
alveolar	NULL
macrophages	NULL
,	NULL
suppressed	NULL
activation	NULL
of	NULL
lung	NULL
NF-KB	NULL
in	NULL
the	NULL
inflammatory	NULL
model	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
bronchoalveolar	NULL
lavage	NULL
levels	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-	NULL
«	NULL
@	NULL
)	NULL
and	NULL
the	NULL
CXC	NULL
chemokine	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
,	NULL
were	NULL
substantially	NULL
reduced	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
upregulation	NULL
of	NULL
the	NULL
lung	NULL
vascular	NULL
adhesion	NULL
molecule	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
was	NULL
greatly	NULL
reduced	NULL
by	NULL
intrapulmonary	NULL
instillation	NULL
of	NULL
phosphonate-containing	NULL
liposomes	NULL
.	NULL

Neutrophil	NULL
accumulation	NULL
and	NULL
development	NULL
of	NULL
Tung	NULL
injury	NULL
were	NULL
also	NULL
substantially	NULL
diminished	NULL
.	NULL

Lung	NULL
instillation	NULL
of	NULL
TNF-a	NULL
in	NULL
alveolar	NULL
macrophage-depleted	NULL
rats	NULL
restored	NULL
the	NULL
NF-KB	NULL
activation	NULL
response	NULL
in	NULL
whole	NULL
lung	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
this	NULL
inflammatory	NULL
model	NULL
,	NULL
initial	NULL
activation	NULL
of	NULL
NF-KB	NULL
occurs	NULL
in	NULL
alveolar	NULL
macrophages	NULL
and	NULL
the	NULL
ensuing	NULL
production	NULL
of	NULL
TNF-a	NULL
may	NULL
propagate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
to	NULL
other	NULL
cell	NULL
types	NULL
in	NULL
the	NULL
lung	NULL
.	NULL

Lentsch	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
B.	NULL
J.	NULL
Czermak	NULL
,	NULL
N.	NULL
M.	NULL
Bless	NULL
,	NULL
N.	NULL
Van	NULL
Rooijen	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1999	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
alveolar	NULL
macrophages	NULL
in	NULL
intrapulmo-	NULL
nary	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

20:692-698	NULL
.	NULL

The	NULL
lung	NULL
inflammatory	NULL
response	NULL
is	NULL
regulated	NULL
by	NULL
coordinated	NULL
functions	NULL
of	NULL
cytokines	NULL
,	NULL
chemokines	NULL
,	NULL
and	NULL
adhesion	NULL
molecules	NULL
.	NULL

Acute	NULL
lung	NULL
injury	NULL
induced	NULL
by	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
immune	NULL
complexes	NULL
(	NULL
IgG-ICs	NULL
)	NULL
in	NULL
rats	NULL
has	NULL
allowed	NULL
delineation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
mediators	NULL
in	NULL
the	NULL
inflammatory	NULL
process	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
and	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-1B	NULL
is	NULL
required	NULL
for	NULL
upregulation	NULL
of	NULL
vascular	NULL
adhesion	NULL
molecules	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICA	NULL
and	NULL
E-selectin	NULL
,	NULL
on	NULL
pulmonary	NULL
vascular	NULL
endothelial	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

These	NULL
vascular	NULL
adhesion	NULL
molecules	NULL
,	NULL
in	NULL
cooperation	NULL
with	NULL
(	NULL
Received	NULL
in	NULL
original	NULL
form	NULL
May	NULL
6	NULL
,	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
A	NULL
ugust	NULL
14	NULL
,	NULL
1998	NULL
)	NULL
Address	NULL
correspondence	NULL
to	NULL
:	NULL
Alex	NULL
B.	NULL
Lentsch	NULL
,	NULL
Ph.D.	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Louisville	NULL
,	NULL
J.	NULL
G.	NULL
Brown	NULL
Cancer	NULL
Center	NULL
,	NULL
529	NULL
S.	NULL
Jackson	NULL
St.	NULL
,	NULL
Louisville	NULL
,	NULL
KY	NULL
40202	NULL
.	NULL

E-mail	NULL
:	NULL
ablent01	NULL
@	NULL
ulkyym.louisville.edu	NULL
Abbreviations	NULL
:	NULL
bronchoalveolar	NULL
lavage	NULL
fluid	NULL
,	NULL
BALF	NULL
;	NULL
bovine	NULL
serum	NULL
albu-min	NULL
,	NULL
BSA	NULL
;	NULL
dichloromethylene	NULL
diphosphonate	NULL
,	NULL
CI	NULL
;	NULL
MDP	NULL
;	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
EMSA	NULL
;	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
ICAM-1	NULL
;	NULL
immunoglobulin	NULL
G	NULL
,	NULL
IgG	NULL
;	NULL
immunoglobulin	NULL
G	NULL
immune	NULL
complex	NULL
,	NULL
IgG-IC	NULL
;	NULL
interleukin	NULL
,	NULL
IL	NULL
;	NULL
macrophage	NULL
imflammatory	NULL
protein-2	NULL
,	NULL
MIP-2	NULL
;	NULL
myeloperox-idase	NULL
,	NULL
MPO	NULL
;	NULL
nuclear	NULL
factor	NULL
,	NULL
NF	NULL
;	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
PBS	NULL
;	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
,	NULL
TNF-a	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

-	NULL
Vol	NULL
.	NULL

20	NULL
,	NULL
pp	NULL
.	NULL

692-698	NULL
,	NULL
1999	NULL
Internet	NULL
address	NULL
:	NULL
www.atsjournals.org	NULL
neutrophil	NULL
chemotaxins	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
CXC	NULL
chemokines	NULL
and	NULL
complement	NULL
activation	NULL
products	NULL
)	NULL
,	NULL
mediate	NULL
the	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
into	NULL
the	NULL
alveolar	NULL
space	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Immunostaining	NULL
techniques	NULL
have	NULL
suggested	NULL
that	NULL
alveolar	NULL
macrophages	NULL
are	NULL
the	NULL
primary	NULL
source	NULL
of	NULL
these	NULL
cytokines	NULL
and	NULL
chemokines	NULL
(	NULL
4	NULL
,	NULL
6	NULL
)	NULL
.	NULL

In	NULL
this	NULL
inflammatory	NULL
model	NULL
,	NULL
damage	NULL
to	NULL
lung	NULL
parenchyma	NULL
results	NULL
from	NULL
the	NULL
generation	NULL
and	NULL
release	NULL
of	NULL
oxidants	NULL
and	NULL
pro-teases	NULL
from	NULL
recruited	NULL
neutrophils	NULL
and	NULL
activated	NULL
residential	NULL
macrophages	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
IgG-IC	NULL
model	NULL
of	NULL
lung	NULL
injury	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
kB	NULL
is	NULL
an	NULL
important	NULL
signal	NULL
transduction	NULL
element	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
lung	NULL
inflammatory	NULL
response	NULL
(	NULL
9	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
consists	NULL
of	NULL
a	NULL
heterodimer	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
,	NULL
which	NULL
in	NULL
most	NULL
cells	NULL
is	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
complex	NULL
with	NULL
inhibitory	NULL
proteins	NULL
of	NULL
the	NULL
IB	NULL
family	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Upon	NULL
cell	NULL
stimulation	NULL
,	NULL
IxB	NULL
is	NULL
degraded	NULL
in	NULL
a	NULL
process	NULL
requiring	NULL
the	NULL
function	NULL
of	NULL
the	NULL
268	NULL
proteasome	NULL
.	NULL

The	NULL
free	NULL
``	NULL
activated	NULL
``	NULL
heterodimeric	NULL
NF-KB	NULL
then	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
specific	NULL
promoter	NULL
elements	NULL
and	NULL
induces	NULL
gene	NULL
transcription	NULL
.	NULL

NF-kB	NULL
is	NULL
known	NULL
to	NULL
regulate	NULL
gene	NULL
transcription	NULL
of	NULL
many	NULL
cytokines	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
TNF-a	NULL
,	NULL
IL-1B	NULL
)	NULL
,	NULL
CXC	NULL
chemokines	NULL
(	NULL
of	NULL
the	NULL
IL-8	NULL
family	NULL
)	NULL
,	NULL
and	NULL
endothelial	NULL
adhesion	NULL
molecules	NULL
(	NULL
ICA	NULL
M-1	NULL
,	NULL
E-selectin	NULL
)	NULL
involved	NULL
in	NULL
acute	NULL
lung	NULL
inflammation	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
Lentsch	NULL
,	NULL
Czermak	NULL
,	NULL
Bless	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Alveolar	NULL
Macrophages	NULL
and	NULL
Lung	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
693	NULL
in	NULL
vivo	NULL
that	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
occurs	NULL
in	NULL
alveolar	NULL
macrophages	NULL
long	NULL
before	NULL
any	NULL
evidence	NULL
of	NULL
lung	NULL
inflammation	NULL
(	NULL
9	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
these	NULL
cells	NULL
triggers	NULL
pulmonary	NULL
production	NULL
of	NULL
the	NULL
early	NULL
proinflammatory	NULL
mediators	NULL
.	NULL

Depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
intratracheal	NULL
instillation	NULL
of	NULL
liposomes	NULL
containing	NULL
the	NULL
compound	NULL
dichloromethylene	NULL
diphosphonate	NULL
(	NULL
CI	NULL
,	NULL
MDP	NULL
)	NULL
has	NULL
been	NULL
used	NULL
to	NULL
study	NULL
alveolar	NULL
macrophage	NULL
functions	NULL
in	NULL
vivo	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
liposome-encapsulated	NULL
CI	NULL
MDP	NULL
is	NULL
ingested	NULL
only	NULL
by	NULL
phago-cytic	NULL
cells	NULL
and	NULL
results	NULL
in	NULL
selective	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
without	NULL
damaging	NULL
other	NULL
cell	NULL
types	NULL
in	NULL
the	NULL
lung	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
technique	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
reduces	NULL
lung	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
neutrophil	NULL
recruitment	NULL
in	NULL
a	NULL
model	NULL
of	NULL
lipopolysaccha-ride-induced	NULL
lung	NULL
inflammation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
in	NULL
a	NULL
model	NULL
of	NULL
bacterial	NULL
pneumonia	NULL
,	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
CI	NULL
,	NULL
MDP	NULL
liposomes	NULL
caused	NULL
increased	NULL
lung	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
increased	NULL
lung	NULL
neutrophil	NULL
recruitment	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
stimulus	NULL
may	NULL
dictate	NULL
the	NULL
function	NULL
of	NULL
alveolar	NULL
macrophages	NULL
,	NULL
the	NULL
latter	NULL
studies	NULL
suggest	NULL
that	NULL
under	NULL
special	NULL
circumstances	NULL
there	NULL
may	NULL
be	NULL
non-alveolar	NULL
macrophage	NULL
sources	NULL
of	NULL
TNF-a	NULL
that	NULL
may	NULL
be	NULL
relevant	NULL
during	NULL
the	NULL
development	NULL
of	NULL
lung	NULL
inflammatory	NULL
injury	NULL
.	NULL

Although	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
alveolar	NULL
macrophages	NULL
is	NULL
known	NULL
to	NULL
occur	NULL
early	NULL
in	NULL
lung	NULL
inflammation	NULL
(	NULL
9	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
the	NULL
products	NULL
of	NULL
alveolar	NULL
macrophages	NULL
are	NULL
required	NULL
for	NULL
NF-KB	NULL
activation	NULL
in	NULL
other	NULL
lung	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
current	NULL
studies	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
delineate	NULL
further	NULL
the	NULL
role	NULL
of	NULL
alveolar	NULL
macrophages	NULL
in	NULL
lung	NULL
NF-KB	NULL
activation	NULL
and	NULL
inflammatory	NULL
injury	NULL
induced	NULL
by	NULL
IgG-ICs	NULL
.	NULL

The	NULL
data	NULL
to	NULL
be	NULL
presented	NULL
indicate	NULL
that	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
with	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
suppresses	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
lung	NULL
tissues	NULL
in	NULL
this	NULL
inflammatory	NULL
model	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
accompanied	NULL
by	NULL
reduced	NULL
pulmonary	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
(	NULL
MIP-2	NULL
)	NULL
,	NULL
diminished	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
,	NULL
and	NULL
protection	NULL
against	NULL
lung	NULL
injury	NULL
.	NULL

Furthermore	NULL
,	NULL
lung	NULL
instillation	NULL
of	NULL
TNF-a	NULL
«	NULL
in	NULL
alveolar	NULL
macrophage-depleted	NULL
rats	NULL
restored	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
whole-lung	NULL
tissues	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
NF-KB	NULL
activation	NULL
triggered	NULL
by	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
-ICs	NULL
is	NULL
initiated	NULL
by	NULL
products	NULL
of	NULL
alveolar	NULL
macrophages	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
may	NULL
then	NULL
be	NULL
propagated	NULL
to	NULL
other	NULL
lung	NULL
cells	NULL
by	NULL
products	NULL
of	NULL
activated	NULL
alveolar	NULL
macrophages	NULL
such	NULL
as	NULL
cytokines	NULL
and	NULL
chemokines	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
Liposomes	NULL
composed	NULL
of	NULL
egg	NULL
phosphatidylcholine	NULL
and	NULL
cholesterol	NULL
and	NULL
containing	NULL
either	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
pH	NULL
7.4	NULL
or	NULL
CL	NULL
MDP	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
GmbH	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
were	NULL
synthesized	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
IgG	NULL
anti-bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
ICN	NULL
Biomedi-cals	NULL
,	NULL
Inc.	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
IgG	NULL
antirat-ICAM-1	NULL
and	NULL
nonspecific	NULL
rabbit	NULL
IgG	NULL
were	NULL
obtained	NULL
from	NULL
Accurate	NULL
Chemical	NULL
Company	NULL
(	NULL
Westbury	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Recombi-nant	NULL
murine	NULL
TNF-	NULL
«	NULL
was	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Inc.	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Alveolar	NULL
Macrophage	NULL
Depletion	NULL
Specific	NULL
pathogen-free	NULL
male	NULL
Long-Evans	NULL
rats	NULL
(	NULL
275	NULL
to	NULL
300	NULL
g	NULL
;	NULL
Harlan	NULL
Sprague-Dawley	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
were	NULL
anesthetized	NULL
with	NULL
ketamine	NULL
HCI	NULL
(	NULL
150	NULL
mg/kg	NULL
,	NULL
intraperitoneally	NULL
)	NULL
.	NULL

A	NULL
suspension	NULL
of	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
in	NULL
PBS	NULL
(	NULL
100	NULL
pl	NULL
of	NULL
liposomes	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
500	NULL
pl	NULL
)	NULL
was	NULL
administered	NULL
intratracheally	NULL
during	NULL
inspiration	NULL
.	NULL

A	NULL
s	NULL
a	NULL
control	NULL
,	NULL
PBS-liposomes	NULL
were	NULL
administered	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
.	NULL

All	NULL
subsequent	NULL
interventions	NULL
occurred	NULL
24	NULL
h	NULL
after	NULL
liposome	NULL
instillation	NULL
.	NULL

IgG-IC-Induced	NULL
Alveolitis	NULL
A	NULL
total	NULL
of	NULL
1.5	NULL
mg	NULL
rabbit	NULL
polyclonal	NULL
IgG	NULL
anti-BSA	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
0.3	NULL
ml	NULL
PBS	NULL
was	NULL
instilled	NULL
via	NULL
an	NULL
intratracheal	NULL
catheter	NULL
during	NULL
inspiration	NULL
.	NULL

Immediately	NULL
thereafter	NULL
,	NULL
10	NULL
mg	NULL
BSA	NULL
in	NULL
0.5	NULL
ml	NULL
PBS	NULL
were	NULL
injected	NULL
intravenously	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
pulmonary	NULL
vascular	NULL
permeability	NULL
,	NULL
trace	NULL
amounts	NULL
of	NULL
'	NULL
``	NULL
I-labeled	NULL
BSA	NULL
were	NULL
injected	NULL
intravenously	NULL
.	NULL

Control	NULL
rats	NULL
received	NULL
PBS	NULL
intratracheally	NULL
.	NULL

At	NULL
4	NULL
h	NULL
after	NULL
IgG-IC	NULL
deposition	NULL
,	NULL
rats	NULL
were	NULL
exsanguinated	NULL
,	NULL
the	NULL
pulmonary	NULL
circulation	NULL
was	NULL
flushed	NULL
with	NULL
10	NULL
ml	NULL
saline	NULL
by	NULL
pulmonary	NULL
artery	NULL
injec-tion	NULL
,	NULL
and	NULL
the	NULL
lungs	NULL
were	NULL
surgically	NULL
dissected	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
NF-kB	NULL
activation	NULL
and	NULL
lung	NULL
myeloperoxidase	NULL
(	NULL
MPO	NULL
)	NULL
content	NULL
,	NULL
lungs	NULL
were	NULL
immediately	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
lung	NULL
injury	NULL
was	NULL
quantified	NULL
by	NULL
calculating	NULL
the	NULL
lung	NULL
permeability	NULL
index	NULL
(	NULL
amount	NULL
of	NULL
radioactivity	NULL
[	NULL
'*I-labeled	NULL
BSA	NULL
]	NULL
in	NULL
the	NULL
perfused	NULL
lungs	NULL
divided	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
1.0	NULL
ml	NULL
of	NULL
blood	NULL
obtained	NULL
at	NULL
the	NULL
time	NULL
of	NULL
death	NULL
)	NULL
.	NULL

Lung	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
Nuclear	NULL
extracts	NULL
of	NULL
whole-lung	NULL
tissues	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Deryckere	NULL
and	NULL
Gannon	NULL
(	NULL
18	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
double-stranded	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
5'-GTG	NULL
AGGGGACTTTCCCAGGC-3	NULL
'	NULL
;	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
end-labeled	NULL
with	NULL
triphosphate	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
at	NULL
10	NULL
mCi/ml	NULL
;	NULL
Amersham	NULL
Co.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
protein	NULL
extract	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
and	NULL
35	NULL
fmol	NULL
(	NULL
~	NULL
50,000	NULL
cpm	NULL
,	NULL
Cherenkov	NULL
counting	NULL
)	NULL
of	NULL
oligonucleotide	NULL
were	NULL
performed	NULL
for	NULL
30	NULL
min	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
ethylenediamenetetraacetic	NULL
acid	NULL
[	NULL
EDTA	NULL
]	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.6	NULL
]	NULL
,	NULL
and	NULL
50	NULL
pg/ml	NULL
poly	NULL
[	NULL
dI-dCJ	NULL
;	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Reaction	NULL
volumes	NULL
were	NULL
held	NULL
constant	NULL
to	NULL
15	NULL
wl	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
X	NULL
TBE	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

NF-KB	NULL
activation	NULL
was	NULL
quantitated	NULL
from	NULL
digitized	NULL
autoradiography	NULL
films	NULL
using	NULL
image	NULL
analysis	NULL
software	NULL
(	NULL
Adobe	NULL
Systems	NULL
,	NULL
Inc.	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Bronchoalveolar	NULL
Lavage	NULL
Fluid	NULL
(	NULL
BALF	NULL
)	NULL
Cytokine	NULL
Content	NULL
BALF	NULL
was	NULL
collected	NULL
by	NULL
instilling	NULL
and	NULL
withdrawing	NULL
5	NULL
ml	NULL
of	NULL
sterile	NULL
PBS	NULL
three	NULL
times	NULL
from	NULL
the	NULL
lungs	NULL
via	NULL
an	NULL
intratracheal	NULL
cannula	NULL
.	NULL

BALF	NULL
content	NULL
of	NULL
TNF-	NULL
«	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
standard	NULL
WEHI	NULL
cell	NULL
cytotoxicity	NULL
assay	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
MIP-2	NULL
in	NULL
BALF	NULL
was	NULL
by	NULL
en-zyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
4	NULL
)	NULL
.	NULL

694	NULL
AMERICAN	NULL
JOURNAL	NULL
OF	NULL
RESPIRATORY	NULL
CELL	NULL
AND	NULL
MOLECULAR	NULL
BIOLOGY	NULL
VOL	NULL
.	NULL

20	NULL
1999	NULL
Lung	NULL
Vascular	NULL
Expression	NULL
of	NULL
ICAM-1	NULL
Rats	NULL
were	NULL
injected	NULL
intravenously	NULL
with	NULL
0.5	NULL
wCi	NULL
of	NULL
'*I-labeled	NULL
anti-ICAM-1	NULL
3.75	NULL
h	NULL
after	NULL
induction	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

To	NULL
control	NULL
for	NULL
nonspecific	NULL
binding	NULL
and	NULL
potential	NULL
accumulation	NULL
of	NULL
anti-ICAM-1	NULL
antibody	NULL
in	NULL
lung	NULL
parenchyma	NULL
due	NULL
to	NULL
injury	NULL
,	NULL
0.5	NULL
Ci	NULL
``	NULL
I-labeled	NULL
nonspecific	NULL
rabbit	NULL
IgG	NULL
was	NULL
administered	NULL
in	NULL
a	NULL
separate	NULL
set	NULL
of	NULL
rats	NULL
.	NULL

Fifteen	NULL
minutes	NULL
later	NULL
(	NULL
4	NULL
h	NULL
after	NULL
induction	NULL
of	NULL
lung	NULL
injury	NULL
)	NULL
,	NULL
rats	NULL
were	NULL
killed	NULL
and	NULL
the	NULL
lung	NULL
vascu-lature	NULL
was	NULL
flushed	NULL
with	NULL
10	NULL
ml	NULL
PBS	NULL
.	NULL

Lung	NULL
vascular	NULL
ICA	NULL
M-1	NULL
expression	NULL
(	NULL
binding	NULL
index	NULL
)	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
(	NULL
``	NULL
*I-labeled	NULL
antibody	NULL
)	NULL
in	NULL
perfused	NULL
lungs	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
1.0	NULL
ml	NULL
of	NULL
blood	NULL
obtained	NULL
at	NULL
the	NULL
time	NULL
of	NULL
death	NULL
.	NULL

Lung	NULL
MPO	NULL
Content	NULL
Whole-lung	NULL
MPO	NULL
activity	NULL
was	NULL
quantitated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
whole-lung	NULL
homogenates	NULL
were	NULL
diluted	NULL
in	NULL
50	NULL
mM	NULL
potassium	NULL
phosphate	NULL
buffer	NULL
containing	NULL
0.5	NULL
%	NULL
hexadecyltrimethylammonium	NULL
bromide	NULL
,	NULL
pH	NULL
6.0	NULL
.	NULL

After	NULL
sonication	NULL
and	NULL
two	NULL
freeze-thaw	NULL
cycles	NULL
,	NULL
samples	NULL
were	NULL
centrifuged	NULL
at	NULL
4,000	NULL
X	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
reacted	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
0.3	NULL
mM	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetrameth-ylbenzidine	NULL
(	NULL
1.6	NULL
mM	NULL
)	NULL
.	NULL

MPO	NULL
activity	NULL
was	NULL
assessed	NULL
by	NULL
measuring	NULL
the	NULL
change	NULL
in	NULL
absorbance	NULL
at	NULL
655	NULL
nm	NULL
.	NULL

Statistical	NULL
Analysis	NULL
All	NULL
values	NULL
are	NULL
expressed	NULL
as	NULL
means	NULL
+	NULL
SEM	NULL
.	NULL

Data	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
one-way	NULL
analysis	NULL
of	NULL
variance	NULL
,	NULL
and	NULL
individual	NULL
group	NULL
means	NULL
were	NULL
then	NULL
compared	NULL
with	NULL
a	NULL
Student-New-man-Keuls	NULL
test	NULL
.	NULL

Differences	NULL
were	NULL
considered	NULL
significant	NULL
when	NULL
P	NULL
<	NULL
0.05	NULL
.	NULL

For	NULL
calculations	NULL
of	NULL
percent	NULL
change	NULL
,	NULL
negative	NULL
control	NULL
values	NULL
were	NULL
subtracted	NULL
from	NULL
positive	NULL
control	NULL
and	NULL
treatment	NULL
group	NULL
values	NULL
.	NULL

Results	NULL
Depletion	NULL
of	NULL
Alveolar	NULL
Macrophages	NULL
with	NULL
CI	NULL
,	NULL
MDP-Liposomes	NULL
To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
alveolar	NULL
macrophages	NULL
in	NULL
the	NULL
development	NULL
of	NULL
IgG	NULL
lung	NULL
inflammatory	NULL
injury	NULL
,	NULL
experiments	NULL
were	NULL
initiated	NULL
to	NULL
deplete	NULL
lungs	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
intratracheal	NULL
administration	NULL
of	NULL
CI	NULL
,	NULL
liposomes	NULL
.	NULL

Instillation	NULL
of	NULL
100	NULL
pl	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
1	NULL
ml	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
greater	NULL
than	NULL
70	NULL
%	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
within	NULL
24	NULL
h	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
lung	NULL
instillation	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
the	NULL
liposome	NULL
suspension	NULL
was	NULL
not	NULL
tolerated	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
lower	NULL
dose-volumes	NULL
containing	NULL
100	NULL
pl	NULL
of	NULL
liposomes	NULL
.	NULL

Rats	NULL
received	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
(	NULL
100	NULL
wl	NULL
)	NULL
in	NULL
total	NULL
volumes	NULL
of	NULL
either	NULL
300	NULL
or	NULL
500	NULL
pl	NULL
PBS	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
the	NULL
number	NULL
of	NULL
alveolar	NULL
macrophages	NULL
was	NULL
assessed	NULL
by	NULL
BAL	NULL
.	NULL

Administration	NULL
of	NULL
CIL	NULL
,	NULL
MDP	NULL
-liposomes	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
300	NULL
pl	NULL
produced	NULL
approximately	NULL
53	NULL
%	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
dose	NULL
volume	NULL
was	NULL
increased	NULL
to	NULL
500	NULL
pl	NULL
,	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
decreased	NULL
the	NULL
number	NULL
of	NULL
alveolar	NULL
macrophages	NULL
obtained	NULL
by	NULL
BAL	NULL
by	NULL
74	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
when	NULL
compared	NULL
with	NULL
rats	NULL
receiving	NULL
PBS-liposomes	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Administration	NULL
of	NULL
PBS-liposomes	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
number	NULL
of	NULL
alveolar	NULL
macrophages	NULL
compared	NULL
with	NULL
pretreatment	NULL
with	NULL
500	NULL
pl	NULL
PBS	NULL
alone	NULL
.	NULL

For	NULL
all	NULL
subsequent	NULL
experiments	NULL
in	NULL
which	NULL
alveo-	NULL
lar	NULL
macrophage	NULL
depletion	NULL
was	NULL
carried	NULL
out	NULL
,	NULL
a	NULL
dose	NULL
of	NULL
100	NULL
pl	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
500	NULL
pl	NULL
PBS	NULL
was	NULL
used	NULL
.	NULL

Effects	NULL
of	NULL
Alveolar	NULL
Macrophage	NULL
Depletion	NULL
on	NULL
IgG-IC-Induced	NULL
Activation	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
in	NULL
Lung	NULL
Our	NULL
recent	NULL
studies	NULL
in	NULL
the	NULL
IgG	NULL
-IC	NULL
model	NULL
of	NULL
lung	NULL
injury	NULL
have	NULL
suggested	NULL
that	NULL
lung	NULL
NF-kB	NULL
activation	NULL
is	NULL
prerequisite	NULL
for	NULL
the	NULL
development	NULL
of	NULL
lung	NULL
injury	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Because	NULL
these	NULL
studies	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
alveolar	NULL
macrophages	NULL
in	NULL
vivo	NULL
occurs	NULL
hours	NULL
before	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
whole-lung	NULL
tissues	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
could	NULL
alter	NULL
activation	NULL
in	NULL
whole-lung	NULL
tissues	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
whole	NULL
lungs	NULL
obtained	NULL
4	NULL
h	NULL
after	NULL
onset	NULL
of	NULL
injury	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Lungs	NULL
from	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
and	NULL
subsequently	NULL
challenged	NULL
intratracheally	NULL
with	NULL
PBS	NULL
displayed	NULL
normal	NULL
baseline	NULL
levels	NULL
of	NULL
NF-KB	NULL
activation	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

In	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
and	NULL
challenged	NULL
with	NULL
IgG	NULL
the	NULL
expected	NULL
increase	NULL
in	NULL
lung	NULL
NF-KB	NULL
activation	NULL
was	NULL
found	NULL
.	NULL

Depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
with	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
markedly	NULL
reduced	NULL
the	NULL
extent	NULL
of	NULL
lung	NULL
NF-kB	NULL
activation	NULL
induced	NULL
by	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG-ICs	NULL
.	NULL

When	NULL
EMSA	NULL
blots	NULL
were	NULL
subjected	NULL
to	NULL
image	NULL
analysis	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
,	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
was	NULL
found	NULL
to	NULL
reduce	NULL
IgG	NULL
lung	NULL
NF-KB	NULL
activation	NULL
by	NULL
74	NULL
%	NULL
(	NULL
P	NULL
=	NULL
0.031	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
Alveolar	NULL
Macrophage	NULL
Depletion	NULL
on	NULL
BALF	NULL
Levels	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
MIP-2	NULL
and	NULL
Lung	NULL
Vascular	NULL
Expression	NULL
of	NULL
ICAM-1	NULL
Because	NULL
it	NULL
is	NULL
known	NULL
that	NULL
regulates	NULL
the	NULL
gene	NULL
transcription	NULL
of	NULL
both	NULL
TNF-a	NULL
and	NULL
MIP-2	NULL
,	NULL
and	NULL
in	NULL
view	NULL
of	NULL
the	NULL
fact	NULL
15	NULL
7	NULL
74	NULL
%	NULL
decrease	NULL
0.001	NULL
s	NULL
p	NULL
<	NULL
g	NULL
’	NULL
12	NULL
7	NULL
S	NULL
Q	NULL
_T_	NULL
A	NULL
9	NULL
a	NULL
o	NULL
G	NULL
o	NULL
E	NULL
has	NULL
tes	NULL
io	NULL
5	NULL
9	NULL
§	NULL
0	NULL
PBS	NULL
PBS-	NULL
__	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
jipposomes	NULL
Figure	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
liposomes	NULL
on	NULL
alveolar	NULL
macrophage	NULL
numbers	NULL
.	NULL

Rats	NULL
received	NULL
lung	NULL
instillations	NULL
of	NULL
PBS	NULL
,	NULL
PBS-liposomes	NULL
(	NULL
100	NULL
wl	NULL
)	NULL
,	NULL
or	NULL
(	NULL
100	NULL
pul	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
500	NULL
pl	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
,	NULL
alveolar	NULL
macrophages	NULL
were	NULL
harvested	NULL
by	NULL
BAL	NULL
and	NULL
quantitated	NULL
by	NULL
microcytometry	NULL
.	NULL

Values	NULL
represent	NULL
means	NULL
+	NULL
SEM	NULL
with	NULL
rn	NULL
=	NULL
3	NULL
per	NULL
group	NULL
.	NULL

Lentsch	NULL
,	NULL
Czermak	NULL
,	NULL
Bless	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Alveolar	NULL
Macrophages	NULL
and	NULL
Lung	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
695	NULL
&	NULL
o	NULL
G	NULL
<	NULL
]	NULL
o	NULL
4	NULL
J	NULL
$	NULL
&	NULL
£2	NULL
S5	NULL
&	NULL
S	NULL
@	NULL
x	NULL
&	NULL
PA	NULL
2	NULL
F	NULL
$	NULL
F	NULL
&	NULL
'	NULL
G	NULL
aC	NULL
0	NULL
aa	NULL
#	NULL
i	NULL
(	NULL
200	NULL
-	NULL
]	NULL
PBS-Liposomes	NULL
74	NULL
%	NULL
decrease	NULL
[	NULL
ESS	NULL
DMDP-Liposomes	NULL
p=0.031	NULL
_T_	NULL
,	NULL
150	NULL
4	NULL
res	NULL
Challenge	NULL
NF-	NULL
«	NULL
xB	NULL
Activation	NULL
(	NULL
relative	NULL
intensity	NULL
units	NULL
)	NULL
IgG	NULL
-1C	NULL
Figure	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
on	NULL
NF-KB	NULL
activation	NULL
in	NULL
whole	NULL
lungs	NULL
.	NULL

Rats	NULL
received	NULL
PBS-	NULL
or	NULL
Cl	NULL
,	NULL
;	NULL
somes	NULL
24	NULL
h	NULL
before	NULL
receiving	NULL
intratracheal	NULL
challenge	NULL
with	NULL
either	NULL
PBS	NULL
or	NULL
IgG	NULL
-ICs	NULL
.	NULL

Four	NULL
hours	NULL
after	NULL
PBS	NULL
or	NULL
IgG	NULL
-IC	NULL
challenge	NULL
,	NULL
NF-kB	NULL
binding	NULL
activity	NULL
of	NULL
whole-lung	NULL
nuclear	NULL
extracts	NULL
was	NULL
assessed	NULL
by	NULL
EMSA	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
EMSA	NULL
blots	NULL
were	NULL
digitized	NULL
and	NULL
quantitated	NULL
using	NULL
image	NULL
analysis	NULL
software	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Values	NULL
represent	NULL
means	NULL
*	NULL
SEM	NULL
with	NULL
n	NULL
=	NULL
4	NULL
per	NULL
group	NULL
.	NULL

that	NULL
we	NULL
have	NULL
shown	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
to	NULL
greatly	NULL
reduce	NULL
lung	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
on	NULL
BALF	NULL
levels	NULL
of	NULL
TNF-a	NULL
and	NULL
MIP-2	NULL
proteins	NULL
.	NULL

Using	NULL
a	NULL
WEHI	NULL
cell	NULL
cytotoxicity	NULL
assay	NULL
for	NULL
TNF-	NULL
«	NULL
,	NULL
we	NULL
observed	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
TNF-a	NULL
in	NULL
BALF	NULL
from	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-	NULL
or	NULL
CLMDP-liposomes	NULL
and	NULL
then	NULL
challenged	NULL
intratracheally	NULL
with	NULL
PBS	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Intrapulmonary	NULL
deposition	NULL
of	NULL
IgG	NULL
-ICs	NULL
caused	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
BALF	NULL
TNF-a	NULL
levels	NULL
in	NULL
rats	NULL
treated	NULL
with	NULL
PBS-liposomes	NULL
.	NULL

However	NULL
,	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
with	NULL
CI	NULL
,	NULL
MDP	NULL
liposomes	NULL
caused	NULL
a	NULL
48	NULL
%	NULL
reduction	NULL
(	NULL
P	NULL
=	NULL
0.006	NULL
)	NULL
in	NULL
BALF	NULL
TNF-	NULL
«	NULL
content	NULL
.	NULL

Similar	NULL
effects	NULL
were	NULL
observed	NULL
when	NULL
MIP-2	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

There	NULL
were	NULL
low	NULL
levels	NULL
of	NULL
MIP	NULL
in	NULL
BALF	NULL
from	NULL
rats	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
with	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
MDP	NULL
liposomes	NULL
and	NULL
subsequently	NULL
challenged	NULL
with	NULL
PBS	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
IgG-IC	NULL
deposition	NULL
,	NULL
MIP-2	NULL
levels	NULL
were	NULL
greatly	NULL
increased	NULL
(	NULL
>	NULL
5-fold	NULL
)	NULL
in	NULL
BALF	NULL
from	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
rats	NULL
depleted	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
pretreatment	NULL
with	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
,	NULL
IgG-IC-induced	NULL
increases	NULL
in	NULL
BALF	NULL
MIP-2	NULL
were	NULL
reduced	NULL
by	NULL
78	NULL
%	NULL
(	NULL
P	NULL
=	NULL
0.004	NULL
)	NULL
.	NULL

Upregulation	NULL
of	NULL
pulmonary	NULL
vascular	NULL
ICAM-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
lung	NULL
neutrophil	NULL
accumulation	NULL
and	NULL
full	NULL
development	NULL
of	NULL
tissue	NULL
injury	NULL
in	NULL
this	NULL
model	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Because	NULL
products	NULL
of	NULL
activated	NULL
alveolar	NULL
macrophages	NULL
(	NULL
includ-ing	NULL
TNF-	NULL
«	NULL
)	NULL
are	NULL
known	NULL
to	NULL
be	NULL
related	NULL
to	NULL
ICAM-1	NULL
expression	NULL
(	NULL
1	NULL
)	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
effects	NULL
of	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
on	NULL
lung	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
using	NULL
``	NULL
I-labeled	NULL
antibody	NULL
to	NULL
ICAM-l.	NULL
Pretreatment	NULL
of	NULL
rats	NULL
with	NULL
either	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
baseline	NULL
levels	NULL
of	NULL
ICAM-1	NULL
expression	NULL
after	NULL
intratracheal	NULL
challenge	NULL
with	NULL
PBS	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

In	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
and	NULL
challenged	NULL
with	NULL
IgG	NULL
-ICs	NULL
,	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
expression	NULL
showed	NULL
the	NULL
expected	NULL
increase	NULL
(	NULL
nearly	NULL
3-fold	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
was	NULL
not	NULL
due	NULL
to	NULL
nonspecific	NULL
binding	NULL
or	NULL
sequestration	NULL
of	NULL
antibody	NULL
because	NULL
binding	NULL
indexes	NULL
for	NULL
nonspecific	NULL
rabbit	NULL
IgG	NULL
were	NULL
not	NULL
different	NULL
between	NULL
PBS-challenged	NULL
and	NULL
IgG-IC-challenged	NULL
rats	NULL
(	NULL
0.17	NULL
+	NULL
0.05	NULL
and	NULL
0.20	NULL
+	NULL
0.07	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
rats	NULL
depleted	NULL
of	NULL
alveolar	NULL
macrophages	NULL
with	NULL
CIL	NULL
,	NULL
MDP	NULL
liposomes	NULL
,	NULL
IgG	NULL
-IC-induced	NULL
ICAM-1	NULL
expression	NULL
was	NULL
reduced	NULL
by	NULL
67	NULL
%	NULL
(	NULL
P	NULL
=	NULL
0.035	NULL
)	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

As	NULL
will	NULL
be	NULL
shown	NULL
subsequently	NULL
,	NULL
this	NULL
correlates	NULL
with	NULL
reduced	NULL
accumulation	NULL
of	NULL
neutrophils	NULL
in	NULL
the	NULL
inflamed	NULL
lung	NULL
.	NULL

Effects	NULL
of	NULL
Alveolar	NULL
Macrophage	NULL
Depletion	NULL
on	NULL
Neutrophil	NULL
Recruitment	NULL
and	NULL
Development	NULL
of	NULL
Lung	NULL
Injury	NULL
Because	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
suppressed	NULL
IgG	NULL
-IC-induced	NULL
increases	NULL
in	NULL
lung	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
BALF	NULL
content	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
MIP-2	NULL
(	NULL
Figures	NULL
3A	NULL
and	NULL
3B	NULL
)	NULL
,	NULL
and	NULL
lung	NULL
vascular	NULL
expression	NULL
of	NULL
ICA	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
extent	NULL
to	NULL
which	NULL
these	NULL
effects	NULL
were	NULL
associated	NULL
with	NULL
reduced	NULL
neutrophil	NULL
recruitment	NULL
into	NULL
lung	NULL
and	NULL
development	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

Neutrophil	NULL
recruitment	NULL
into	NULL
lung	NULL
was	NULL
quantitated	NULL
by	NULL
lung	NULL
content	NULL
of	NULL
MPO	NULL
activity	NULL
.	NULL

In	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
and	NULL
challenged	NULL
with	NULL
PBS	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
neutrophil	NULL
accumulation	NULL
in	NULL
lung	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

In	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
and	NULL
then	NULL
challenged	NULL
with	NULL
IgG-ICs	NULL
,	NULL
lung	NULL
MPO	NULL
content	NULL
was	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
significantly	NULL
increased	NULL
from	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
and	NULL
challenged	NULL
with	NULL
PBS	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4A	NULL
,	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
with	NULL
CI	NULL
,	NULL
MDP	NULL
liposomes	NULL
decreased	NULL
IgG	NULL
-IC-induced	NULL
MPO	NULL
values	NULL
by	NULL
59	NULL
%	NULL
(	NULL
P	NULL
=	NULL
0.002	NULL
)	NULL
.	NULL

Lung	NULL
injury	NULL
was	NULL
quantitated	NULL
by	NULL
changes	NULL
in	NULL
vascular	NULL
permeability	NULL
as	NULL
measured	NULL
by	NULL
leakage	NULL
of	NULL
'	NULL
``	NULL
I-albumin	NULL
into	NULL
lung	NULL
parenchyma	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
lung	NULL
injury	NULL
in	NULL
rats	NULL
challenged	NULL
with	NULL
PBS	NULL
after	NULL
pretreatment	NULL
with	NULL
either	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG-ICs	NULL
caused	NULL
significant	NULL
lung	NULL
injury	NULL
in	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
,	NULL
with	NULL
a	NULL
5.5-fold	NULL
increase	NULL
in	NULL
the	NULL
permeability	NULL
index	NULL
.	NULL

Rats	NULL
depleted	NULL
of	NULL
alveolar	NULL
macrophages	NULL
with	NULL
CI	NULL
,	NULL
MDP	NULL
-liposomes	NULL
incurred	NULL
significantly	NULL
less	NULL
lung	NULL
injury	NULL
(	NULL
55	NULL
%	NULL
reduction	NULL
,	NULL
P	NULL
=	NULL
0.015	NULL
)	NULL
compared	NULL
with	NULL
positive	NULL
control	NULL
rats	NULL
pretreated	NULL
with	NULL
PBS-liposomes	NULL
.	NULL

696	NULL
AMERICAN	NULL
JOURNAL	NULL
OF	NULL
RESPIRATORY	NULL
CELL	NULL
AND	NULL
MOLECULAR	NULL
BIOLOGY	NULL
VOL	NULL
.	NULL

20	NULL
1999	NULL
[	NULL
-~	NULL
]	NULL
PBS-Liposomes	NULL
A.	NULL
BAL	NULL
TNFG	NULL
‘	NULL
DMDP-Liposomes	NULL
150	NULL
48	NULL
%	NULL
decrease	NULL
=0.006	NULL
120	NULL
-	NULL
=-80	NULL
38	NULL
=	NULL
5	NULL
€	NULL
T	NULL
D	NULL
C	NULL
E-	NULL
=	NULL
ao	NULL
|	NULL
30	NULL
0	NULL
B.	NULL
BAL	NULL
MIP-2	NULL
250	NULL
78	NULL
%	NULL
decrease	NULL
p=0.004	NULL
200	NULL
_T_	NULL
N	NULL
a	NULL
150	NULL
[	NULL
€	NULL
3B	NULL
®	NULL
5	NULL
10	NULL
|	NULL
_I	NULL
50	NULL
-l	NULL
,	NULL
|	NULL
_-C	NULL
.	NULL

Lung	NULL
Vascular	NULL
ICAM-1	NULL
0.30	NULL
7	NULL
&	NULL
[	NULL
e	NULL
]	NULL
67	NULL
%	NULL
decrease	NULL
a	NULL
p=0.035	NULL
tA	NULL
0.25	NULL
3	NULL
x	NULL
3	NULL
W	NULL
5	NULL
hry	NULL
S	NULL
0.20	NULL
=	NULL
?	NULL

T4	NULL
5s	NULL
J	NULL
C	NULL
'	NULL
:	NULL
8	NULL
,	NULL
0.15	NULL
$	NULL
a3	NULL
E	NULL
®	NULL
ld	NULL
0.10	NULL
-	NULL
>	NULL
»	NULL
PBS	NULL
1gG-IC	NULL
Challenge	NULL
Figure	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
on	NULL
BALF	NULL
content	NULL
of	NULL
TNF-a	NULL
(	NULL
A	NULL
)	NULL
,	NULL
MIP-2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
expression	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Rats	NULL
received	NULL
PBS-	NULL
or	NULL
C1	NULL
,	NULL
MDP	NULL
liposomes	NULL
24	NULL
h	NULL
before	NULL
receiving	NULL
intratracheal	NULL
challenge	NULL
with	NULL
either	NULL
PBS	NULL
or	NULL
IgG	NULL
-IC	NULL
.	NULL

Analysis	NULL
of	NULL
BALF	NULL
and	NULL
measurements	NULL
of	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
were	NULL
performed	NULL
4	NULL
h	NULL
after	NULL
challenge	NULL
with	NULL
PBS	NULL
or	NULL
IgG-IC	NULL
.	NULL

Values	NULL
represent	NULL
means	NULL
+	NULL
SEM	NULL
with	NULL
r	NULL
»	NULL
=	NULL
5	NULL
(	NULL
BALF	NULL
TNF-a	NULL
and	NULL
MIP-2	NULL
)	NULL
or	NULL
n	NULL
=	NULL
10	NULL
(	NULL
lung	NULL
vascular	NULL
ICAM-1	NULL
)	NULL
per	NULL
group	NULL
.	NULL

[	NULL
__	NULL
]	NULL
PBS-Liposomes	NULL
DMDP-Liposomes	NULL
A	NULL
.	NULL

Lung	NULL
MPO	NULL
Content	NULL
2.5	NULL
59	NULL
%	NULL
decrease	NULL
p=0.002	NULL
2.0	NULL
_	NULL
I_	NULL
1.5	NULL
4	NULL
1.0	NULL
MPO	NULL
Activity	NULL
(	NULL
Absorbance	NULL
at	NULL
655	NULL
nm	NULL
)	NULL
0.5	NULL
0.0	NULL
--	NULL
-	NULL
B8	NULL
]	NULL
B	NULL
.	NULL

Lung	NULL
Vascular	NULL
Permeability	NULL
55	NULL
%	NULL
decrease	NULL
p=0.015	NULL
--	NULL
0.7	NULL
7	NULL
0.6	NULL
0.5	NULL
0.4	NULL
0.3	NULL
--	NULL
§	NULL
0.2	NULL
Permeability	NULL
Index	NULL
0.1	NULL
|	NULL
\I	NULL
0.0	NULL
PBS	NULL
IgG	NULL
Challenge	NULL
Figure	NULL
4	NULL
.	NULL

Effects	NULL
of	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
on	NULL
lung	NULL
MPO	NULL
content	NULL
(	NULL
A	NULL
)	NULL
and	NULL
lung	NULL
vascular	NULL
permeability	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
IgG	NULL
-IC	NULL
model	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

Rats	NULL
received	NULL
PBS-	NULL
or	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
24	NULL
h	NULL
before	NULL
receiving	NULL
intratracheal	NULL
challenge	NULL
with	NULL
either	NULL
PBS	NULL
or	NULL
IgG	NULL
-IC	NULL
.	NULL

Measurements	NULL
of	NULL
lung	NULL
MPO	NULL
and	NULL
permeability	NULL
were	NULL
performed	NULL
4	NULL
h	NULL
after	NULL
challenge	NULL
with	NULL
PBS	NULL
or	NULL
IgG-IC	NULL
.	NULL

Values	NULL
represent	NULL
means	NULL
+	NULL
SEM	NULL
with	NULL
n	NULL
=	NULL
5	NULL
per	NULL
group	NULL
.	NULL

TNF-a	NULL
Restores	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
Lung	NULL
Because	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
suppressed	NULL
lung	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
reduced	NULL
lung	NULL
NF-KB	NULL
activation	NULL
,	NULL
experiments	NULL
were	NULL
designed	NULL
to	NULL
determine	NULL
whether	NULL
ex-ogenous	NULL
administration	NULL
of	NULL
TNF-a	NULL
would	NULL
lead	NULL
to	NULL
NF-kB	NULL
activation	NULL
in	NULL
lung	NULL
of	NULL
macrophage-depleted	NULL
rats	NULL
.	NULL

Alveolar	NULL
macrophage-depleted	NULL
rats	NULL
received	NULL
lung	NULL
instillation	NULL
of	NULL
PBS	NULL
or	NULL
500	NULL
ng	NULL
of	NULL
murine	NULL
TNF-a	NULL
,	NULL
and	NULL
lung	NULL
NF-KB	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
EMSA	NULL
4	NULL
h	NULL
later	NULL
.	NULL

In	NULL
macrophage-depleted	NULL
rats	NULL
,	NULL
lung	NULL
instillation	NULL
of	NULL
PBS	NULL
did	NULL
not	NULL
cause	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
lung	NULL
instillation	NULL
of	NULL
TNF-a	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
nuclear	NULL
NF-KB	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
products	NULL
of	NULL
activated	NULL
alveolar	NULL
macrophages	NULL
,	NULL
such	NULL
as	NULL
TNF-	NULL
«	NULL
,	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
NF-KB	NULL
activation	NULL
in	NULL
the	NULL
inflamed	NULL
lung	NULL
.	NULL

Lentsch	NULL
,	NULL
Czermak	NULL
,	NULL
Bless	NULL
,	NULL
et	NULL
al	NULL
.	NULL

:	NULL
Alveolar	NULL
Macrophages	NULL
and	NULL
Lung	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
697	NULL
PBS	NULL
TNFa	NULL
%	NULL
Figure	NULL
5	NULL
.	NULL

Effects	NULL
of	NULL
lung	NULL
in-¢	NULL
stillation	NULL
of	NULL
PBS	NULL
or	NULL
TNF-a	NULL
«	NULL
on	NULL
lung	NULL
NF-KB	NULL
activation	NULL
in	NULL
alveolar	NULL
macrophage-depleted	NULL
rats	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
intratracheal	NULL
administration	NULL
of	NULL
CI	NULL
,	NULL
MDP-liposomes	NULL
,	NULL
rats	NULL
received	NULL
lung	NULL
instillations	NULL
of	NULL
PBS	NULL
or	NULL
500	NULL
ng	NULL
murine	NULL
TNF-a	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
300	NULL
pl	NULL
.	NULL

Four	NULL
hours	NULL
later	NULL
,	NULL
lung	NULL
NF-KB	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
EMSA	NULL
.	NULL

E	NULL
T	NULL
Alveolar	NULL
Macrophage-Depleted	NULL
Lungs	NULL
Discussion	NULL
Increasing	NULL
evidence	NULL
suggests	NULL
an	NULL
important	NULL
role	NULL
for	NULL
NF-KB	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
lung	NULL
inflammation	NULL
.	NULL

Studies	NULL
in	NULL
vitro	NULL
have	NULL
shown	NULL
that	NULL
regulates	NULL
gene	NULL
expression	NULL
of	NULL
cytokines	NULL
(	NULL
TNF-	NULL
«	NULL
,	NULL
IL-1B	NULL
)	NULL
,	NULL
chemokines	NULL
(	NULL
MIP-2	NULL
,	NULL
CINC	NULL
)	NULL
,	NULL
and	NULL
adhesion	NULL
molecules	NULL
(	NULL
ICA	NULL
M-1	NULL
,	NULL
E-selectin	NULL
)	NULL
,	NULL
which	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
lung	NULL
inflammatory	NULL
injury	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

These	NULL
in	NULL
vitro	NULL
findings	NULL
are	NULL
supported	NULL
by	NULL
studies	NULL
in	NULL
humans	NULL
with	NULL
acute	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
showing	NULL
enhanced	NULL
NF-xB	NULL
activation	NULL
in	NULL
alveolar	NULL
macrophages	NULL
recovered	NULL
by	NULL
BAL	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
studies	NULL
in	NULL
vivo	NULL
have	NULL
shown	NULL
an	NULL
association	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
expression	NULL
of	NULL
cytokines	NULL
,	NULL
chemokines	NULL
,	NULL
and	NULL
vascular	NULL
adhesion	NULL
molecules	NULL
(	NULL
22	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
in	NULL
vivo	NULL
have	NULL
demonstrated	NULL
that	NULL
lung	NULL
NF-KB	NULL
activation	NULL
is	NULL
suppressed	NULL
by	NULL
antioxidants	NULL
(	NULL
23	NULL
)	NULL
or	NULL
anti-inflammatory	NULL
cytokines	NULL
(	NULL
9	NULL
)	NULL
.	NULL

This	NULL
results	NULL
in	NULL
decreased	NULL
proinflammatory	NULL
mediator	NULL
expression	NULL
and	NULL
reduced	NULL
inflammatory	NULL
injury	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
activation	NULL
of	NULL
may	NULL
be	NULL
central	NULL
to	NULL
the	NULL
development	NULL
of	NULL
pulmonary	NULL
inflammation	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
NF-kB	NULL
activation	NULL
during	NULL
lung	NULL
inflammatory	NULL
injury	NULL
is	NULL
known	NULL
to	NULL
require	NULL
both	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
,	NULL
which	NULL
seem	NULL
to	NULL
operate	NULL
as	NULL
autocrine/paracrine	NULL
stimu-lators	NULL
of	NULL
alveolar	NULL
macrophages	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Alveolar	NULL
macrophage	NULL
activation	NULL
is	NULL
an	NULL
initial	NULL
event	NULL
in	NULL
the	NULL
genesis	NULL
of	NULL
lung	NULL
inflammatory	NULL
reactions	NULL
.	NULL

In	NULL
the	NULL
rat	NULL
model	NULL
of	NULL
injury	NULL
induced	NULL
by	NULL
intrapulmonary	NULL
deposition	NULL
of	NULL
IgG-ICs	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
early	NULL
activation	NULL
of	NULL
alveolar	NULL
macrophages	NULL
occurs	NULL
in	NULL
an	NULL
NF-B-dependent	NULL
manner	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NF-KB	NULL
activation	NULL
in	NULL
alveolar	NULL
macrophages	NULL
in	NULL
vivo	NULL
occurs	NULL
prior	NULL
to	NULL
NF-KB	NULL
activation	NULL
in	NULL
whole-lung	NULL
tissues	NULL
,	NULL
suggesting	NULL
that	NULL
products	NULL
of	NULL
activated	NULL
alveolar	NULL
macrophages	NULL
are	NULL
required	NULL
to	NULL
stimulate	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
in	NULL
other	NULL
lung-cell	NULL
types	NULL
.	NULL

The	NULL
present	NULL
data	NULL
support	NULL
that	NULL
hypothesis	NULL
because	NULL
depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
attenuated	NULL
NF-KB	NULL
activation	NULL
in	NULL
whole-lung	NULL
tissues	NULL
and	NULL
decreased	NULL
BALF	NULL
content	NULL
of	NULL
proinflammatory	NULL
mediators	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
lung	NULL
instillation	NULL
of	NULL
TNF-a	NULL
in	NULL
alveolar	NULL
macrophage-depleted	NULL
rats	NULL
induced	NULL
NF-xB	NULL
activation	NULL
in	NULL
whole	NULL
lungs	NULL
.	NULL

Although	NULL
alveolar	NULL
macrophages	NULL
are	NULL
considered	NULL
a	NULL
major	NULL
source	NULL
of	NULL
TNF-a	NULL
in	NULL
the	NULL
lung	NULL
,	NULL
alveolar	NULL
macrophage	NULL
depletion	NULL
reduced	NULL
BAL	NULL
TNF-a	NULL
by	NULL
only	NULL
48	NULL
%	NULL
.	NULL

Similarly	NULL
,	NULL
IgG	NULL
-IC-induced	NULL
increases	NULL
in	NULL
pulmonary	NULL
vascular	NULL
permeability	NULL
were	NULL
decreased	NULL
by	NULL
55	NULL
%	NULL
in	NULL
rats	NULL
depleted	NULL
of	NULL
alveolar	NULL
macrophages	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
important	NULL
sources	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
lung	NULL
,	NULL
such	NULL
as	NULL
interstitial	NULL
macrophages	NULL
and	NULL
perhaps	NULL
nonmacrophage	NULL
cell	NULL
types	NULL
,	NULL
that	NULL
may	NULL
cooperatively	NULL
contribute	NULL
to	NULL
tissue	NULL
injury	NULL
.	NULL

A	NULL
Iternatively	NULL
,	NULL
the	NULL
small	NULL
amount	NULL
of	NULL
alveolar	NULL
macrophages	NULL
remaining	NULL
after	NULL
CI	NULL
,	NULL
MDP	NULL
liposome	NULL
administration	NULL
(	NULL
~	NULL
26	NULL
%	NULL
)	NULL
may	NULL
have	NULL
produced	NULL
a	NULL
disproportionately	NULL
large	NULL
amount	NULL
of	NULL
TNF-	NULL
«	NULL
.	NULL

Treatment	NULL
with	NULL
CIL	NULL
,	NULL
MDP-liposomes	NULL
,	NULL
which	NULL
on	NULL
average	NULL
resulted	NULL
in	NULL
a	NULL
74	NULL
%	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
lavageable	NULL
alveolar	NULL
macrophages	NULL
,	NULL
almost	NULL
completely	NULL
abrogated	NULL
BALF	NULL
content	NULL
of	NULL
the	NULL
chemokine	NULL
MIP-2	NULL
(	NULL
78	NULL
%	NULL
reduction	NULL
)	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
our	NULL
earlier	NULL
report	NULL
suggesting	NULL
that	NULL
activated	NULL
alveolar	NULL
macrophages	NULL
are	NULL
the	NULL
primary	NULL
source	NULL
of	NULL
MIP-2	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Damage	NULL
to	NULL
lung	NULL
tissues	NULL
after	NULL
IgG	NULL
-IC	NULL
deposition	NULL
is	NULL
mediated	NULL
primarily	NULL
by	NULL
neutrophil-derived	NULL
oxidants	NULL
and	NULL
pro-teases	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
25	NULL
)	NULL
.	NULL

In	NULL
rats	NULL
depleted	NULL
of	NULL
alveolar	NULL
macrophages	NULL
,	NULL
pulmonary	NULL
neutrophil	NULL
accumulation	NULL
was	NULL
greatly	NULL
reduced	NULL
,	NULL
as	NULL
was	NULL
the	NULL
extent	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

Neutrophil	NULL
recruitment	NULL
into	NULL
lung	NULL
induced	NULL
by	NULL
IgG	NULL
-IC	NULL
deposition	NULL
is	NULL
known	NULL
to	NULL
depend	NULL
on	NULL
vascular	NULL
expression	NULL
of	NULL
ICA	NULL
M-1	NULL
and	NULL
production	NULL
of	NULL
CXC	NULL
chemokines	NULL
,	NULL
which	NULL
include	NULL
MIP-2	NULL
and	NULL
CINC	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Alveolar	NULL
macrophage	NULL
depletion	NULL
by	NULL
CIL	NULL
,	NULL
MDP	NULL
significantly	NULL
reduced	NULL
both	NULL
MIP-2	NULL
content	NULL
in	NULL
BALF	NULL
and	NULL
pulmonary	NULL
vascular	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

Decreased	NULL
levels	NULL
of	NULL
MIP	NULL
-2	NULL
can	NULL
be	NULL
ascribed	NULL
to	NULL
the	NULL
physical	NULL
removal	NULL
of	NULL
its	NULL
cellular	NULL
source	NULL
,	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Decreased	NULL
expression	NULL
of	NULL
ICAM-1	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
decreased	NULL
availability	NULL
of	NULL
TNF-a	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
regulate	NULL
ICA	NULL
M-1	NULL
expression	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
reduced	NULL
IgG	NULL
-IC-induced	NULL
lung	NULL
NF-kB	NULL
activation	NULL
and	NULL
TNF-a	NULL
production	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
treatment	NULL
with	NULL
the	NULL
anti-inflammatory	NULL
cytokines	NULL
IL-10	NULL
and	NULL
IL-13	NULL
.	NULL

Both	NULL
IL-10	NULL
and	NULL
IL-13	NULL
suppress	NULL
alveolar	NULL
macrophage	NULL
function	NULL
by	NULL
preserving	NULL
cytosolic	NULL
expression	NULL
of	NULL
the	NULL
inhibitory	NULL
protein	NULL
IxBa	NULL
,	NULL
thus	NULL
preventing	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
9	NULL
)	NULL
.	NULL

At	NULL
least	NULL
in	NULL
the	NULL
case	NULL
of	NULL
IL-10	NULL
,	NULL
suppression	NULL
of	NULL
NF-KB	NULL
activation	NULL
in	NULL
macrophages	NULL
in	NULL
vitro	NULL
is	NULL
known	NULL
to	NULL
prevent	NULL
transcription	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
IgG-IC-induced	NULL
lung	NULL
inflammation	NULL
,	NULL
administration	NULL
of	NULL
IL-10	NULL
or	NULL
IL-13	NULL
greatly	NULL
suppressed	NULL
lung	NULL
production	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
subsequent	NULL
lung	NULL
injury	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
in	NULL
vivo	NULL
that	NULL
IL-10	NULL
and	NULL
IL-13	NULL
suppress	NULL
alveolar	NULL
macrophage	NULL
NF-KB	NULL
activation	NULL
,	NULL
preventing	NULL
proinflammatory	NULL
cytokine	NULL
production	NULL
and	NULL
reducing	NULL
lung	NULL
inflammation	NULL
and	NULL
injury	NULL
.	NULL

The	NULL
findings	NULL
of	NULL
those	NULL
studies	NULL
,	NULL
combined	NULL
with	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
,	NULL
suggest	NULL
that	NULL
specific	NULL
inhibitors	NULL
of	NULL
NF-KB	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
proteasome	NULL
inhibitors	NULL
,	NULL
IxBa	NULL
ki-nase	NULL
inhibitors	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

may	NULL
be	NULL
targeted	NULL
for	NULL
delivery	NULL
to	NULL
alveolar	NULL
macrophages	NULL
by	NULL
liposome	NULL
encapsulation	NULL
.	NULL

This	NULL
could	NULL
represent	NULL
a	NULL
potent	NULL
therapeutic	NULL
strategy	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
acute	NULL
lung	NULL
inflammation	NULL
in	NULL
which	NULL
products	NULL
of	NULL
lung	NULL
macrophages	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
events	NULL
leading	NULL
to	NULL
lung	NULL
injury	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Vaporciyan	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
T.	NULL
Tamatani	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
regulates	NULL
in	NULL
vivo	NULL
intrapulmonary	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

142:1739-1749	NULL
.	NULL

2	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
J.	NULL
Varani	NULL
,	NULL
M.	NULL
K.	NULL
Dame	NULL
,	NULL
C.	NULL
L.	NULL
Lane	NULL
,	NULL
C.	NULL
W.	NULL
Smith	NULL
,	NULL
D.	NULL
C.	NULL
698	NULL
wo	NULL
ta	NULL
~	NULL
go	NULL
10	NULL
.	NULL

1	NULL
w	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

Anderson	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1991	NULL
.	NULL

Role	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ELAM-1	NULL
)	NULL
in	NULL
neutrophil-mediated	NULL
lung	NULL
injury	NULL
in	NULL
rats	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:1396-1406.	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
G.	NULL
P.	NULL
Wilson	NULL
,	NULL
R.	NULL
F.	NULL
Todd	NULL
,	NULL
C.	NULL
W.	NULL
Smith	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
J.	NULL
Varani	NULL
,	NULL
T.	NULL
B.	NULL
Issekutz	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
T.	NULL
Tamatani	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
T.	NULL
Tamatani	NULL
,	NULL
J.	NULL
R.	NULL
Rusche	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Vaporciyan	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1993	NULL
.	NULL

Role	NULL
of	NULL
B	NULL
;	NULL
,	NULL
B	NULL
;	NULL
integrins	NULL
and	NULL
ICAM-1	NULL
in	NULL
lung	NULL
injury	NULL
after	NULL
deposition	NULL
of	NULL
IgG	NULL
and	NULL
IgA	NULL
immune	NULL
complexes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:2407-2417.	NULL
.	NULL

Shanley	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
H.	NULL
Schmal	NULL
,	NULL
R.	NULL
L.	NULL
Warner	NULL
,	NULL
E.	NULL
Schmid	NULL
,	NULL
H.	NULL
P.	NULL
Fried	NULL
]	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1997	NULL
.	NULL

Requirement	NULL
for	NULL
C-X-C	NULL
chemokines	NULL
(	NULL
macrophage	NULL
inflammatory	NULL
protein-2	NULL
and	NULL
cytokine-induced	NULL
neutrophil	NULL
chemoattractant	NULL
)	NULL
in	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:3439-3448.	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
E.	NULL
Schmid	NULL
,	NULL
B.	NULL
Beck-Schimmer	NULL
,	NULL
G.	NULL
O.	NULL
Till	NULL
,	NULL
H.	NULL
P.	NULL
Fried	NULL
]	NULL
,	NULL
R.	NULL
B.	NULL
Brauer	NULL
,	NULL
T.	NULL
E.	NULL
Hugli	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
R.	NULL
L.	NULL
Warner	NULL
,	NULL
K.	NULL
J.	NULL
Johnson	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1996	NULL
.	NULL

Requirement	NULL
and	NULL
role	NULL
of	NULL
C5a	NULL
in	NULL
acute	NULL
lung	NULL
inflammatory	NULL
injury	NULL
in	NULL
rats	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98:503-512.	NULL
.	NULL

Warren	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
K.	NULL
R.	NULL
Yabroff	NULL
,	NULL
D.	NULL
G.	NULL
Remick	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
S.	NULL
W.	NULL
Chensue	NULL
,	NULL
R.	NULL
G.	NULL
Kunkel	NULL
,	NULL
K.	NULL
J.	NULL
Johnson	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
participates	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
immune	NULL
complex	NULL
alveolitis	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

$	NULL
4:1873-1882.	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1981	NULL
.	NULL

Role	NULL
of	NULL
oxygen	NULL
metabolites	NULL
in	NULL
im-	NULL
mune	NULL
complex	NULL
injury	NULL
of	NULL
lung	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

126:2365-2369.	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
P.	NULL
E.	NULL
Desrochers	NULL
,	NULL
A.	NULL
M.	NULL
Chinnaiyan	NULL
,	NULL
D.	NULL
F.	NULL
Gibbs	NULL
,	NULL
J.	NULL
Varani	NULL
,	NULL
K.	NULL
J.	NULL
Johnson	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Weiss	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
suppression	NULL
of	NULL
immune	NULL
complex-induced	NULL
alveolitis	NULL
by	NULL
secretory	NULL
leukoproteinase	NULL
inhibitor	NULL
and	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases	NULL
2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:11523-11527	NULL
.	NULL

Lentsch	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
T.	NULL
P.	NULL
Shanley	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1997	NULL
.	NULL

In	NULL
vivo	NULL
suppression	NULL
of	NULL
NF-kB	NULL
and	NULL
preservation	NULL
of	NULL
IxBa	NULL
by	NULL
interleukin-10	NULL
and	NULL
inter-leukin-13	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:2443-2448	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-kappa	NULL
B	NULL
and	NULL
I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-683.	NULL
.	NULL

Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
P.	NULL
Bacuerle	NULL
,	NULL
and	NULL
P.	NULL
Vassalli	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
tumor	NULL
ne	NULL
crosis	NULL
factor	NULL
alpha	NULL
transcription	NULL
in	NULL
macrophages	NULL
:	NULL
involvement	NULL
of	NULL
four	NULL
kappa	NULL
B-like	NULL
motifs	NULL
and	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
forms	NULL
of	NULL
NF-kappa	NULL
B.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1498-1506	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Marois	NULL
,	NULL
J.	NULL
Garoufalis	NULL
,	NULL
M.	NULL
D'Addario	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
I.	NULL
Kwan	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
H.	NULL
Nguyen	NULL
,	NULL
and	NULL
G.	NULL
Bensi	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
functional	NULL
NF-kappa	NULL
B	NULL
site	NULL
in	NULL
the	NULL
human	NULL
interleukin	NULL
1	NULL
beta	NULL
promoter	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
positive	NULL
autoregulatory	NULL
loop	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6231-6240	NULL
.	NULL

Konishi	NULL
,	NULL
K.	NULL
,	NULL
Y.	NULL
Takata	NULL
,	NULL
M.	NULL
Yamamoto	NULL
,	NULL
K.	NULL
Yomogida	NULL
,	NULL
K.	NULL
Watanabe	NULL
,	NULL
S.	NULL
Tsu-rufiji	NULL
,	NULL
and	NULL
M.	NULL
Fujioka	NULL
.	NULL

1993	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
rat	NULL
neutrophil	NULL
chemoattractant	NULL
Gro	NULL
.	NULL

Gene	NULL
126:285-286	NULL
.	NULL

Collins	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
A.	NULL
S.	NULL
Neish	NULL
,	NULL
M.	NULL
Z.	NULL
Whitley	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
T.	NULL
Ma-niatis	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
mole-cules	NULL
:	NULL
NF-kappa	NULL
B	NULL
and	NULL
cytokine-inducible	NULL
enhancers	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

9:899-909	NULL
.	NULL

Berg	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
S.	NULL
T.	NULL
Lee	NULL
,	NULL
T.	NULL
Thepen	NULL
,	NULL
C.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Tsan	NULL
.	NULL

1993	NULL
.	NULL

Depletion	NULL
of	NULL
alveolar	NULL
macrophages	NULL
by	NULL
liposome-encapsulated	NULL
dichloromethylene	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
19	NULL
.	NULL

20	NULL
.	NULL

2	NULL
w	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

2	NULL
go	NULL
AMERICAN	NULL
JOURNAL	NULL
OF	NULL
RESPIRATORY	NULL
CELL	NULL
AND	NULL
MOLECULAR	NULL
BIOLOGY	NULL
VOL	NULL
.	NULL

20	NULL
1999	NULL
diphosphonate	NULL
.	NULL

J.	NULL
Appl	NULL
.	NULL

Physiol	NULL
.	NULL

74:2812-2819	NULL
.	NULL

Broug-Holub	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
B.	NULL
Toews	NULL
,	NULL
J.	NULL
F.	NULL
van	NULL
Iwaarden	NULL
,	NULL
R.	NULL
M.	NULL
Stricter	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
R.	NULL
Paine	NULL
,	NULL
III	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Standiford	NULL
.	NULL

1997	NULL
.	NULL

Alveolar	NULL
macrophages	NULL
are	NULL
required	NULL
for	NULL
protective	NULL
pulmonary	NULL
defenses	NULL
in	NULL
murine	NULL
Klebsiella	NULL
pneu-monia	NULL
:	NULL
elimination	NULL
of	NULL
alveolar	NULL
macrophages	NULL
increases	NULL
neutrophil	NULL
recruitment	NULL
but	NULL
decreases	NULL
bacterial	NULL
clearance	NULL
and	NULL
survival	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

65	NULL
:	NULL
1139-1146	NULL
.	NULL

Van	NULL
Rooijen	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
A.	NULL
Sanders	NULL
.	NULL

1994	NULL
.	NULL

Liposome	NULL
mediated	NULL
depletion	NULL
of	NULL
macrophages	NULL
:	NULL
mechanism	NULL
of	NULL
action	NULL
,	NULL
preparation	NULL
of	NULL
liposomes	NULL
and	NULL
applica-tions	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
174:83-93.	NULL
.	NULL

Deryckere	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
F.	NULL
Gannon	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
one-hour	NULL
minipreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA	NULL
-binding	NULL
proteins	NULL
from	NULL
animal	NULL
tissues	NULL
.	NULL

Biotechniques	NULL
16:405	NULL
.	NULL

Espevik	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J.	NULL
Nissen-Meyer	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
highly	NULL
sensitive	NULL
cell	NULL
line	NULL
,	NULL
WEHI	NULL
164	NULL
clone	NULL
13	NULL
,	NULL
for	NULL
measuring	NULL
cytotoxic	NULL
factor	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
from	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
95:99-105	NULL
.	NULL

Suzuki	NULL
,	NULL
K.	NULL
,	NULL
O.	NULL
H.	NULL
Sasagawa	NULL
,	NULL
S.	NULL
Sakatani	NULL
,	NULL
and	NULL
T.	NULL
Fujikura	NULL
.	NULL

1983	NULL
.	NULL

Assay	NULL
method	NULL
for	NULL
myeloperoxidase	NULL
in	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132:345-352.	NULL
.	NULL

Schwartz	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
E.	NULL
E.	NULL
Moore	NULL
,	NULL
F.	NULL
A.	NULL
Moore	NULL
,	NULL
R.	NULL
Shenkar	NULL
,	NULL
P.	NULL
Moine	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Haenel	NULL
,	NULL
and	NULL
E.	NULL
Abraham	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
factor-kappa	NULL
B	NULL
is	NULL
activated	NULL
in	NULL
alveolar	NULL
macrophages	NULL
from	NULL
patients	NULL
with	NULL
acute	NULL
respiratory	NULL
distress	NULL
syn-drome	NULL
.	NULL

Crif	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

24:1285-1292	NULL
.	NULL

Manning	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
F.	NULL
P.	NULL
Bell	NULL
,	NULL
C.	NULL
L.	NULL
Rosenbloom	NULL
,	NULL
J.	NULL
G.	NULL
Chosay	NULL
,	NULL
C.	NULL
A.	NULL
Sim-mons	NULL
,	NULL
J.	NULL
L.	NULL
Northrup	NULL
,	NULL
R.	NULL
J.	NULL
Shebuski	NULL
,	NULL
C.	NULL
J.	NULL
Dunn	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Anderson	NULL
.	NULL

1995	NULL
.	NULL

NF-KB	NULL
is	NULL
activated	NULL
during	NULL
acute	NULL
inflammation	NULL
in	NULL
vivo	NULL
in	NULL
association	NULL
with	NULL
elevated	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecule	NULL
gene	NULL
expression	NULL
and	NULL
leukocyte	NULL
recruitment	NULL
.	NULL

J.	NULL
Inflamm	NULL
.	NULL

45:283-296	NULL
.	NULL

Blackwell	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
T.	NULL
R.	NULL
Blackwell	NULL
,	NULL
E.	NULL
P.	NULL
Holden	NULL
,	NULL
B.	NULL
W.	NULL
Christman	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Christman	NULL
.	NULL

1996	NULL
.	NULL

In	NULL
vivo	NULL
antioxidant	NULL
treatment	NULL
suppresses	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
activation	NULL
and	NULL
neutrophilic	NULL
lung	NULL
inflammation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
:	NULL
1630-1637	NULL
.	NULL

Lentsch	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
B.	NULL
J.	NULL
Czermak	NULL
,	NULL
N.	NULL
M.	NULL
Bless	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1998	NULL
.	NULL

NF-kB	NULL
activation	NULL
during	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
:	NULL
requirements	NULL
for	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
$	NULL
but	NULL
not	NULL
complement	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

152:1327-1336	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1974	NULL
.	NULL

Acute	NULL
immunologic	NULL
pulmonary	NULL
alveo-litis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

54:349-357	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
M.	NULL
I.	NULL
Siegel	NULL
,	NULL
R.	NULL
W.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Billah	NULL
.	NULL

1994	NULL
.	NULL

IL-10	NULL
inhibits	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononu-clear	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:811-816	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
M.	NULL
I.	NULL
Siegel	NULL
,	NULL
R.	NULL
W.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Billah	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
inhibits	NULL
nuclear	NULL
factor	NULL
kappaB	NULL
(	NULL
NFkB	NULL
)	NULL
activation	NULL
in	NULL
human	NULL
monocytes	NULL
:	NULL
IL-10	NULL
and	NULL
IL-4	NULL
suppress	NULL
cytokine	NULL
synthesis	NULL
by	NULL
different	NULL
mecha-nisms	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:9558-9563.	NULL
.	NULL

Mulligan	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
R.	NULL
L.	NULL
Warner	NULL
,	NULL
J.	NULL
L.	NULL
Foreback	NULL
,	NULL
T.	NULL
P.	NULL
Shanley	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1997	NULL
.	NULL

Protective	NULL
effects	NULL
of	NULL
IL-4	NULL
,	NULL
IL-10	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-13	NULL
in	NULL
IgG	NULL
immune	NULL
complex-induced	NULL
lung	NULL
injury	NULL
:	NULL
role	NULL
of	NULL
endogenous	NULL
IL-12	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3483-3489	NULL
.	NULL

